Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-18T16:00:15.295Z Has data issue: false hasContentIssue false

Fatty acid composition of the postmortem corpus callosum of patients with schizophrenia, bipolar disorder, or major depressive disorder

Published online by Cambridge University Press:  23 March 2020

K. Hamazaki*
Affiliation:
Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama351-0198, Japan Department of Public Health, Faculty of Medicine, University of Toyama, Toyama City, Toyama9300194, Japan
M. Maekawa
Affiliation:
Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama351-0198, Japan
T. Toyota
Affiliation:
Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama351-0198, Japan
B. Dean
Affiliation:
The Florey Institute of Neuroscience and Mental Health, Parkville, VictoriaAustralia
T. Hamazaki
Affiliation:
Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama351-0198, Japan
T. Yoshikawa
Affiliation:
Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama351-0198, Japan
*
Corresponding author at: Department of Public Health, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama City, Toyama 9300194, Japan. E-mail address:keihama@med.u-toyama.ac.jp (K. Hamazaki).
Get access

Abstract

Background

Studies investigating the relationship between n-3 polyunsaturated fatty acid (PUFA) levels and psychiatric disorders have thus far focused mainly on analyzing gray matter, rather than white matter, in the postmortem brain. In this study, we investigated whether PUFA levels showed abnormalities in the corpus callosum, the largest area of white matter, in the postmortem brain tissue of patients with schizophrenia, bipolar disorder, or major depressive disorder.

Methods

Fatty acids in the phospholipids of the postmortem corpus callosum were evaluated by thin-layer chromatography and gas chromatography. Specimens were evaluated for patients with schizophrenia (n = 15), bipolar disorder (n = 15), or major depressive disorder (n = 15) and compared with unaffected controls (n = 15).

Results

In contrast to some previous studies, no significant differences were found in the levels of PUFAs or other fatty acids in the corpus callosum between patients and controls. A subanalysis by sex gave the same results. No significant differences were found in any PUFAs between suicide completers and non-suicide cases regardless of psychiatric disorder diagnosis.

Conclusions

Patients with psychiatric disorders did not exhibit n-3 PUFAs deficits in the postmortem corpus callosum relative to the unaffected controls, and the corpus callosum might not be involved in abnormalities of PUFA metabolism. This area of research is still at an early stage and requires further investigation.

Type
Original article
Copyright
Copyright © Elsevier Masson SAS 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Abbreviations: AA, arachidonic acid; CVD, cardiovascular disease; DHA, docosahexaenoic acid; PMI, postmortem interval; PUFAs, polyunsaturated fatty acids.

References

Horrobin, DFGlen, AIVaddadi, KThe membrane hypothesis of schizophrenia. Schizophr Res 1994; 13: 195207.CrossRefGoogle ScholarPubMed
Hamazaki, KHamazaki, TInadera, HPolyunsaturated fatty acids and their related enzymes in postmortem brain tissues of patients with psychiatric disorders. Curr Psychopharmacol 2013; 2: 6672.CrossRefGoogle Scholar
Muller, CPReichel, MMuhle, CRhein, CGulbins, EKornhuber, JBrain membrane lipids in major depression and anxiety disorders. Biochim Biophys Acta 2015; 1851: 10521065.CrossRefGoogle ScholarPubMed
McNamara, RKJandacek, RRider, TTso, PHahn, CGRichtand, NMet al.Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications. Schizophr Res 2007; 91: 3750.CrossRefGoogle ScholarPubMed
McNamara, RKJandacek, RRider, TTso, PStanford, KEHahn, CGet al.Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder. Psychiatry Res 2008; 160: 285299.CrossRefGoogle Scholar
McNamara, RKHahn, CGJandacek, RRider, TTso, PStanford, KEet al.Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol Psychiatry 2007; 62: 1724.CrossRefGoogle ScholarPubMed
Horrobin, DFManku, MSHillman, HIain, AGlen, MFatty acid levels in the brains of schizophrenics and normal controls. Biol Psychiatry 1991; 30: 795805.CrossRefGoogle ScholarPubMed
Conklin, SMRunyan, CALeonard, SReddy, RDMuldoon, MFYao, JKAge-related changes of n-3 and n-6 polyunsaturated fatty acids in the anterior cingulate cortex of individuals with major depressive disorder. Prostaglandins Leukot Essent Fatty Acids 2010; 82: 111119.CrossRefGoogle ScholarPubMed
Taha, AYCheon, YMa, KRapoport, SIRao, JSAltered fatty acid concentrations in prefrontal cortex of schizophrenic patients. J Psychiatr Res 2013; 47: 636643.CrossRefGoogle ScholarPubMed
Tatebayashi, YNihonmatsu-Kikuchi, NHayashi, YYu, XSoma, MIkeda, KAbnormal fatty acid composition in the frontopolar cortex of patients with affective disorders. Transl Psychiatry 2012;2:e204.CrossRefGoogle ScholarPubMed
Lalovic, ALevy, ECanetti, LSequeira, AMontoudis, ATurecki, GFatty acid composition in postmortem brains of people who completed suicide. J Psychiatry Neurosci 2007; 32: 363370.Google ScholarPubMed
Igarashi, MMa, KGao, FKim, HWGreenstein, DRapoport, SIet al.Brain lipid concentrations in bipolar disorder. J Psychiatr Res 2010; 44: 177182.CrossRefGoogle ScholarPubMed
Hamazaki, KMaekawa, MToyota, TDean, BHamazaki, TYoshikawa, TFatty acid composition of the postmortem prefrontal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder. Psychiatry Res 2015; 227: 353359.CrossRefGoogle ScholarPubMed
Hamazaki, KMaekawa, MToyota, TIwayama, YDean, BHamazaki, Tet al.Fatty acid composition and fatty acid binding protein expression in the postmortem frontal cortex of patients with schizophrenia: a case-control study. Schizophr Res 2016; 171: 225232. http://dx.doi.org/10.1016/j.schres.2016.01.014.CrossRefGoogle ScholarPubMed
Landen, MDavidsson, PGottfries, CGMansson, JEBlennow, KReduction of the synaptophysin level but normal levels of glycerophospholipids in the gyrus cinguli in schizophrenia. Schizophr Res 2002; 55: 8388.CrossRefGoogle Scholar
Hamazaki, KChoi, KHKim, HYPhospholipid profile in the postmortem hippocampus of patients with schizophrenia and bipolar disorder: no changes in docosahexaenoic acid species. J Psychiatr Res 2010; 44: 688693.CrossRefGoogle ScholarPubMed
Hamazaki, KHamazaki, TInadera, HFatty acid composition in the postmortem amygdala of patients with schizophrenia, bipolar disorder, and major depressive disorder. J Psychiatr Res 2012; 46: 10241028.CrossRefGoogle ScholarPubMed
Hamazaki, KHamazaki, TInadera, HAbnormalities in the fatty acid composition of the postmortem entorhinal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder. Psychiatry Res 2013; 210: 346350.CrossRefGoogle ScholarPubMed
McNamara, RKRider, TJandacek, RTso, PAbnormal fatty acid pattern in the superior temporal gyrus distinguishes bipolar disorder from major depression and schizophrenia and resembles multiple sclerosis. Psychiatry Res 2014; 215: 560567.CrossRefGoogle ScholarPubMed
Yao, JKLeonard, SReddy, RDMembrane phospholipid abnormalities in postmortem brains from schizophrenic patients. Schizophr Res 2000; 42: 717.CrossRefGoogle ScholarPubMed
Hulshoff Pol, HESchnack, HGMandl, RCCahn, WCollins, DLEvans, ACet al.Focal white matter density changes in schizophrenia: reduced interhemispheric connectivity. Neuroimage 2004; 21: 2735.CrossRefGoogle Scholar
Yurgelun-Todd, DASilveri, MMGruber, SARohan, MLPimentel, PJWhite matter abnormalities observed in bipolar disorder: a diffusion tensor imaging study. Bipolar Disord 2007; 9: 504512.CrossRefGoogle ScholarPubMed
Williams, MRSharma, PFung, KLPearce, RKHirsch, SRMaier, MAxonal myelin increase in the callosal genu in depression but not schizophrenia. Psychol Med 2015; 45: 21452155. http://dx.doi.org/10.1017/S0033291715000136.CrossRefGoogle Scholar
Gazzaniga, MSCerebral specialization and interhemispheric communication: does the corpus callosum enable the human condition?. Brain 2000; 123(Pt 7): 12931326.CrossRefGoogle ScholarPubMed
Trapp, BDBernsohn, JEssential fatty acid deficiency and CNS myelin. Biochemical and morphological observations. J Neurol Sci 1978; 37: 249266.CrossRefGoogle ScholarPubMed
Salvati, SNatali, FAttorri, LDi Benedetto, RLeonardi, FDi Biase, Aet al.Eicosapentaenoic acid stimulates the expression of myelin proteins in rat brain. J Neurosci Res 2008; 86: 776784.CrossRefGoogle ScholarPubMed
Peters, BDMachielsen, MWHoen, WPCaan, MWMalhotra, AKSzeszko, PRet al.Polyunsaturated fatty acid concentration predicts myelin integrity in early-phase psychosis. Schizophr Bull 2013; 39: 830838.CrossRefGoogle ScholarPubMed
Hirashima, FParow, AMStoll, ALDemopulos, CMDamico, KERohan, MLet al.Omega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorder. Am J Psychiatry 2004; 161: 19221924.CrossRefGoogle Scholar
Chhetry, BTHezghia, AMiller, JMLee, SRubin-Falcone, HCooper, TBet al.Omega-3 polyunsaturated fatty acid supplementation and white matter changes in major depression. J Psychiatr Res 2016; 75: 6574.CrossRefGoogle ScholarPubMed
Amminger, GPSchafer, MRKlier, CMSlavik, JMHolzer, IHolub, Met al.Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals. Mol Psychiatry 2012; 17: 11501152.CrossRefGoogle ScholarPubMed
Dean, BPavey, GChai, SWMendelsohn, FAOThe localisation and quantification of molecular changes in the human brain using in situ radioligand binding and autoradiography Sydney: Gordon & Breach Science Publishers; 1999Google Scholar
Kingsbury, AEFoster, OJNisbet, APCairns, NBray, LEve, DJet al.Tissue pH as an indicator of mRNA preservation in human postmortem brain. Brain Res Mol Brain Res 1995; 28: 311318.CrossRefGoogle Scholar
Scarr, EUm, JYCowie, TFDean, BCholinergic muscarinic M4 receptor gene polymorphisms: a potential risk factor and pharmacogenomic marker for schizophrenia. Schizophr Res 2013; 146: 279284.CrossRefGoogle Scholar
Hill, CKeks, NRoberts, SOpeskin, KDean, BMacKinnon, Aet al.Problem of diagnosis in postmortem brain studies of schizophrenia. Am J Psychiatry 1996; 153: 533537.Google ScholarPubMed
Roberts, SBHill, CADean, BKeks, NAOpeskin, KCopolov, DLConfirmation of the diagnosis of schizophrenia after death using DSM-IV: a Victorian experience. Aust N Z J Psychiatry 1998; 32: 7376.CrossRefGoogle Scholar
Bligh, EGDyer, WJA rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911917.CrossRefGoogle ScholarPubMed
Schwarz, EPrabakaran, SWhitfield, PMajor, HLeweke, FMKoethe, Det al.High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides. J Proteome Res 2008; 7: 42664277.CrossRefGoogle ScholarPubMed
Umhau, JCZhou, WCarson, RERapoport, SIPolozova, ADemar, Jet al.Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography. J Lipid Res 2009; 50: 12591268.CrossRefGoogle ScholarPubMed
Chen, SZhang, HPu, HWang, GLi, WLeak, RKet al.n-3 PUFA supplementation benefits microglial responses to myelin pathology. Sci Rep 2014;4:7458.CrossRefGoogle ScholarPubMed
Lewis, MDHibbeln, JRJohnson, JELin, YHHyun, DYLoewke, JDSuicide deaths of active-duty US military and omega-3 fatty acid status: a case-control comparison. J Clin Psychiatry 2011; 72: 15851590.CrossRefGoogle ScholarPubMed
Huan, MHamazaki, KSun, YItomura, MLiu, HKang, Wet al.Suicide attempt and n-3 fatty acid levels in red blood cells: a case-control study in China. Biol Psychiatry 2004; 56: 490496.CrossRefGoogle ScholarPubMed
McNamara, RKJandacek, RRider, TTso, PDwivedi, YRoberts, RCet al.Fatty acid composition of the postmortem prefrontal cortex of adolescent male and female suicide victims. Prostaglandins Leukot Essent Fatty Acids 2009; 80: 1926.CrossRefGoogle ScholarPubMed
Cheon, YPark, JYModi, HRKim, HWLee, HJChang, Let al.Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E(2) concentration in rat brain. J Neurochem 2011; 119: 364376.CrossRefGoogle ScholarPubMed
Modi, HRTaha, AYKim, HWChang, LRapoport, SICheon, YChronic clozapine reduces rat brain arachidonic acid metabolism by reducing plasma arachidonic acid availability. J Neurochem 2013; 124: 376387.CrossRefGoogle ScholarPubMed
Khan, MMEvans, DRGunna, VScheffer, REParikh, VVMahadik, SPReduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics. Schizophr Res 2002; 58: 110.CrossRefGoogle ScholarPubMed
Evans, DRParikh, VVKhan, MMCoussons, CBuckley, PFMahadik, SPRed blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment. Prostaglandins Leukot Essent Fatty Acids 2003; 69: 393399.CrossRefGoogle ScholarPubMed
Hibbeln, JRMakino, KKMartin, CEDickerson, FBoronow, JFenton, WSSmoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder. Biol Psychiatry 2003; 53: 431441.CrossRefGoogle ScholarPubMed
Pawlosky, RJSalem, N Jr.Perspectives on alcohol consumption: liver polyunsaturated fatty acids and essential fatty acid metabolism. Alcohol 2004; 34: 2733.CrossRefGoogle ScholarPubMed
Matsumoto, JSugiura, YYuki, DHayasaka, TGoto-Inoue, NZaima, Net al.Abnormal phospholipids distribution in the prefrontal cortex from a patient with schizophrenia revealed by matrix-assisted laser desorption/ionization imaging mass spectrometry. Anal Bioanal Chem 2011; 400: 19331943.CrossRefGoogle ScholarPubMed
Supplementary material: File

Hamazaki et al. supplementary material

Table S1

Download Hamazaki et al. supplementary material(File)
File 44.5 KB
Supplementary material: File

Hamazaki et al. supplementary material

Table S2

Download Hamazaki et al. supplementary material(File)
File 47.6 KB
Supplementary material: File

Hamazaki et al. supplementary material

Table S3

Download Hamazaki et al. supplementary material(File)
File 47.1 KB
Supplementary material: File

Hamazaki et al. supplementary material

Table S4

Download Hamazaki et al. supplementary material(File)
File 37.9 KB
Submit a response

Comments

No Comments have been published for this article.